Drug
Aliskiren
Aliskiren: highest development phase Phase 3, developed by Novartis. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Aliskiren NCT00344110 | Phase 3 | Hypertension |
| Aliskiren NCT00294710 | Phase 3 | Hypertension |
| Aliskiren 150 mg NCT01125514 | Phase 2 | Heart Failure |
Latest
No recent events.
Follow Aliskiren on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.